The 7-diethylamino-substituted 3-acylcoumarin-oxime derivative (compound 7f, bearing a diethylamino group at the C-7 position of the coumarin ring) can be considered a promising scaffold for developing new and more potent MAOI drugs for treating neurodegenerative disorders.
KOLAWOLE et al. (Fri,) studied this question.